Kaste M - Search Results

1

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P. Hacke W, et al. Among authors: kaste m. Lancet. 1998 Oct 17;352(9136):1245-51. doi: 10.1016/s0140-6736(98)08020-9. Lancet. 1998. PMID: 9788453 Clinical Trial.

2

Nimodipine after resuscitation from out-of-hospital ventricular fibrillation. A placebo-controlled, double-blind, randomized trial.

Roine RO, Kaste M, Kinnunen A, Nikki P, Sarna S, Kajaste S. Roine RO, et al. Among authors: kaste m. JAMA. 1990 Dec 26;264(24):3171-7. JAMA. 1990. PMID: 2255026 Clinical Trial.

3

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).

Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Höxter G, Mahagne MH, et al. Hacke W, et al. Among authors: kaste m. JAMA. 1995 Oct 4;274(13):1017-25. JAMA. 1995. PMID: 7563451 Clinical Trial.

4

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

CAPRIE Steering Committee. CAPRIE Steering Committee. Lancet. 1996 Nov 16;348(9038):1329-39. doi: 10.1016/s0140-6736(96)09457-3. Lancet. 1996. PMID: 8918275 Clinical Trial.

5

Thrombolytic therapy for acute ischaemic stroke. ECASS Study Group.

Fieschi C, Hacke W, Kaste M, Toni D, Lesaffre E. Fieschi C, et al. Among authors: kaste m. Lancet. 1997 Nov 15;350(9089):1476; author reply 1477. doi: 10.1016/s0140-6736(05)64241-9. Lancet. 1997. PMID: 9371188 No abstract available.

6

The ECASS 3-hour cohort. Secondary analysis of ECASS data by time stratification. ECASS Study Group. European Cooperative Acute Stroke Study.

Steiner T, Bluhmki E, Kaste M, Toni D, Trouillas P, von Kummer R, Hacke W. Steiner T, et al. Among authors: kaste m. Cerebrovasc Dis. 1998 Jul-Aug;8(4):198-203. doi: 10.1159/000015851. Cerebrovasc Dis. 1998. PMID: 9684058 Clinical Trial.

7

Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. GAIN International Investigators.

Lees KR, Asplund K, Carolei A, Davis SM, Diener HC, Kaste M, Orgogozo JM, Whitehead J. Lees KR, et al. Among authors: kaste m. Lancet. 2000 Jun 3;355(9219):1949-54. doi: 10.1016/s0140-6736(00)02326-6. Lancet. 2000. PMID: 10859040 Clinical Trial.

8

NXY-059 for acute ischemic stroke.

Lees KR, Zivin JA, Ashwood T, Davalos A, Davis SM, Diener HC, Grotta J, Lyden P, Shuaib A, Hårdemark HG, Wasiewski WW; Stroke-Acute Ischemic NXY Treatment (SAINT I) Trial Investigators. Lees KR, et al. N Engl J Med. 2006 Feb 9;354(6):588-600. doi: 10.1056/NEJMoa052980. N Engl J Med. 2006. PMID: 16467546 Free article. Clinical Trial.

9

Snake venom, vampire bat saliva, or rt-PA: time matters.

Kaste M. Kaste M. Lancet. 2006 Nov 25;368(9550):1845-6. doi: 10.1016/S0140-6736(06)69750-X. Lancet. 2006. PMID: 17126698 No abstract available.

10

Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage.

Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T; FAST Trial Investigators. Mayer SA, et al. N Engl J Med. 2008 May 15;358(20):2127-37. doi: 10.1056/NEJMoa0707534. N Engl J Med. 2008. PMID: 18480205 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

537 results

Search Page

Filters